IP Library Granted Patent US 7,507,811
Granted Patent B2
US 7,507,811 · App. 11/633,306 · Granted Mar 24, 2009

siRNA targeting KRAS

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,507,811
App. No.
11/633,306
Granted
Mar 24, 2009
Kind
B2
Abstract

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.

Claims (15)

1. An siRNA molecule, consisting of: (a) a sense region and an antisense region, wherein said sense region and said antisense region together form a duplex region consisting of 19-30 base pairs and said antisense region comprises a sequence that is the complement of SEQ. ID. NO. 461; and (b) from zero to four overhang regions, wherein each overhang region is six or fewer nucleotides in length.

2. The siRNA molecule of claim 1 , wherein said antisense region and said sense region are each 19-25 nucleotides in length.

3. The siRNA molecule of claim 2 , wherein said antisense region and said sense region are each 19 nucleotides in length.

4. The siRNA molecule of claim 1 , wherein said antisense region is 100% complementary to a region of a target mRNA.

5. The siRNA molecule of claim 1 , wherein said siRNA molecule has at least one overhang region.

6. The siRNA molecule of claim 1 , wherein said siRNA molecule has no overhang regions.

7. The siRNA molecule of claim 2 , wherein said siRNA molecule has at least one overhang region.

8. The siRNA molecule of claim 2 , wherein said siRNA molecule has no overhang regions.

9. The siRNA molecule of claim 3 , wherein said siRNA molecule has at least one overhang region.

10. The siRNA molecule of claim 3 , wherein said siRNA molecule has no overhang regions.

11. A chemically synthesized double stranded siRNA molecule that directs cleavage of an mRNA via RNA interference, wherein:

a. each strand of said double stranded siRNA molecule is between 19 and 30 nucleotides in length; and

b. one strand of said double stranded siRNA molecule comprises a sequence that is the complement of SEQ. ID. NO. 461.

12. The chemically synthesized double siRNA molecule of claim 11 , wherein each strand of said double stranded siRNA molecule is 19 nucleotides in length.

13. An siRNA molecule, wherein said siRNA molecule consists of: (a) a sense region, wherein said sense region consists of a sequence that is SEQ. ID. NO. 461, and an antisense region, wherein said antisense region consists of a sequence that is the complement of SEQ. ID. NO. 461; and (b) from zero to four overhang regions, wherein each overhang region is six or fewer nucleotides in length.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2014
From: KHVOROVA, ANSTASIA; REYNOLDS, ANGELA; LEAKE, DEVIN; MARSHALL, WILLIAM; READ, STEVEN; SCARINGE, STEPHEN
To: DHARMACON, INC.
Reel/Frame 032802/0504 →
CHANGE OF NAME Recorded May 1, 2014
From: DHARMACON, INC.
To: THERMO FISHER SCIENTIFIC BIOSCIENCES INC.
Reel/Frame 032808/0454 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2014
From: KHVOROVA, ANASTASIA; LEAKE, DEVIN; MARSHALL, WILLIAM; READ, STEVEN; SCARINGE, STEPHEN; REYNOLDS, ANGELA
To: DHARMACON, INC.
Reel/Frame 032793/0820 →
CHANGE OF NAME Recorded Apr 30, 2014
From: DHARMACON, INC.
To: THERMO FISHER SCIENTIFIC BIOSCIENCES INC.
Reel/Frame 032795/0681 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2014
From: THERMO FISHER SCIENTIFIC BIOSCIENCES INC.
To: THERMO FISHER SCIENTIFIC INC.
Reel/Frame 032723/0262 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2007
From: KHVOROVA, ANASTASIA; REYNOLDS, ANGELA; LEAKE, DEVIN; MARSHALL, WILLIAM; SCARINGE, STEPHEN
To: DHARMACON, INC.
Reel/Frame 018808/0322 →